Buy One Get One free -Llimited Time Offer X
Olvas is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP. Secondary and off-label uses of Olvas have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Olvas. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Olvas also has some side effects, the most common being Upper respiratory tract infection. Apart from the aforementioned side effects, Olvas can also lead to other problems, which have been listed below. Such side effects of Olvas normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Olvas has a Severe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Olvas's effects on the liver, heart and kidney, if any, have been listed below.
Olvas is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) are examples of such conditions. Other conditions have been mentioned below in the Olvas contraindications section.
Additionally, Olvas may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Olvas is considered not safe while driving, and is not addictive.
Olvas is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Olvas is used -
Moderate
Mild
Common
Is the use of Olvas safe for pregnant women?
Pregnant women may get severe side effects after taking Olvas. If you are pregnant, do not take Olvas without a doctor's advice.
Is the use of Olvas safe during breastfeeding?
Olvas has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olvas on the Kidneys?
Olvas has very mild side effects on the kidneys.
What is the effect of Olvas on the Liver?
Olvas may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Olvas on the Heart?
Olvas has very mild side effects on the heart.
Olvas should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olvas unless your doctor advises you to do so -
Is this Olvas habit forming or addictive?
No, you will not get addicted to Olvas.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Olvas can make you feel drowsy.
Is it safe?
Yes, but take Olvas only as per medical advice.
Is it able to treat mental disorders?
No, Olvas cannot treat any kind of mental disorder.
Interaction between Food and Olvas
Taking Olvas with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olvas
Taking Olvas with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173